Orforglipron is a promising weight loss pill that could be a huge growth catalyst for Eli Lilly. The Food and Drug Administration has pushed back the target action date on the drug by nearly two weeks ...
Novo Nordisk's weight loss pill could give the company's numbers a big boost this year.
Buy the Roundhill GLP-1 & Weight Loss ETF (OZEM) for diversified GLP-1 exposure, attractive valuation vs Eli Lilly, and AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results